Lifeboat Foundation

GM Defense, a subsidiary of General Motors, was recently awarded a contract to develop next-generation SUVs for the government’s fleet.

This specific contract was awarded by the US Department of State, and the vehicles will be built to support the Diplomatic Security Service. Diplomatic Security is a federal law enforcement agency charged with securing diplomatic assets and personnel. In 2,020 GM Defense also got the contract to build the army’s new infantry squad vehicle based on the Chevrolet Colorado ZR2. That particular contract was more extensive and, at the time of writing, valued at $213.4 million. The eventual goal was 2,065 vehicles.

The UK government has approved Europe’s first field trials of Crispr-edited wheat. The experiments will be conducted in Hertfordshire by the agricultural science institute Rothamsted Research.

The Rothamsted project is aiming to produce wheat with lower levels of the amino acid asparagine. When bread is baked or toasted, asparagine is converted into acrylamide – a carcinogenic contaminant that requires close monitoring under EU law.

Laboratory and greenhouse studies have already shown Crispr can be used to create wheat plants that produce much lower levels of asparagine. Rothamsted Research says that the new five-year project will examine ‘how the plants fare in the field and whether asparagine concentrations continue to be low in grain produced under field conditions’.

This magnifying glass was used to sharpen X-ray images for the first time using NASA

Established in 1,958 the National Aeronautics and Space Administration (NASA) is an independent agency of the United States Federal Government that succeeded the National Advisory Committee for Aeronautics (NACA). It is responsible for the civilian space program, as well as aeronautics and aerospace research. It’s vision is “To discover and expand knowledge for the benefit of humanity.”

In a press statement from the UK government, the work is described as a “world first.” The material is being used as part of a trial, meaning that the UK government will keep a close eye on the newly-laid surface over the coming years to discern whether graphene can be used more widely to increase the durability and lifespan of roads.

The concept has been meticulously tested in labs, now it’s time for a real-world application.

More treatments are available for Covid-19 as hospitalizations spike, but some drugs are sitting on the shelves unused.

As record daily Covid-19 hospitalizations and deaths this month in the US have pushed the pandemic to new crisis levels, senior government health officials have lamented that many patients are not getting the drugs — including monoclonal antibodies, antivirals, and corticosteroids — available to treat the disease, leaving many doses unused.

“Even with a vaccine, we know we will not prevent every infection,” said US Surgeon General Jerome Adams on January 14 during a press conference. “So today we want to remind everyone that for those of you who do contract Covid, we have excellent treatments to keep you out of the hospital, to keep you out of the ICU, to help you recover quickly.”

US Secretary of Commerce Gina Raimondo has announced that the Commerce Department has established a high-level committee to advise the President and other federal agencies on a range of issues related to artificial intelligence (AI). Working with the National AI Initiative Office (NAIIO) in the White House Office of Science and Technology Policy (OSTP), the Department is now seeking to recruit top-level candidates to serve on the committee.

A formal notice describing the National Artificial Intelligence Advisory Committee (NAIAC) and the call for nominations for the committee and its Subcommittee on Artificial Intelligence and Law Enforcement appears in the Federal Register published today.

“AI presents an enormous opportunity to tackle the biggest issues of our time, strengthen our technological competitiveness, and be an engine for growth in nearly every sector of the economy,” said Secretary Raimondo. “But we must be thoughtful, creative, and wise in how we address the challenges that accompany these new technologies. That includes, but is not limited to, ensuring that President Biden’s comprehensive commitment to advancing equity and racial justice extends to our development and use of AI technology. This committee will help the federal government to do that by providing insights into a full range of issues raised by AI.”

The biggest threat to our success is moving too slowly and refusing to change.

In June, a previously flown Falcon 9 booster lofted a new-generation Global Positioning Satellite for the US Space Force. This marked a watershed moment for the US military and the concept of reusable rockets, as the Space Force entrusted a satellite worth about half a billion dollars to the new technology.

Now, thanks to a recent news release from the US Space Force, we have a little more insight into why the Space Force is leaning into reusable rockets and other technology from innovative companies such as SpaceX.

Continue reading “The Space Force is starting to lean into innovative launch concepts” »

“When the final tests are completed in the future, South Korea will become the eighth country in the world that has developed an advanced supersonic fighter,” a government statement said.

South Korea unveiled its homegrown supersonic jet fighter on Friday, joining an exclusive club of military aviation giants and setting the stage for a $5.2 billion program it hopes will be a top export driver and jobs creator.

Once operational, the KF-21 jet is expected to be armed with a range of air-to-air and air-to-surface missiles — and possibly even air-launched cruise missiles.

Continue reading “South Korea launches first homegrown supersonic jet fighter” »

Australians with COVID-19 who are at risk of hospitalisation will now have access to an additional antibody treatment, as the Therapeutic Goods Administration (TGA) announced today it has granted provisional approval for sotrovimab to be used in Australia.

Earlier this month, the Australian Government secured an initial allocation of over 7,700 doses of the novel monoclonal antibody treatment sotrovimab and a first shipment is already in the country and ready to be deployed through the National Medical Stockpile from next week.

The sotrovimab treatment requires a single dose to be administered through an intravenous (IV) infusion in a health care facility and has been shown to reduce hospitalisation or death by 79 per cent in adults with mild to moderate COVID-19, who are at risk of developing severe COVID-19.